|
What Is CAGE Code 09GL2 and Its Importance? |
|
CAGE Code 09GL2 is a unique identifier assigned to Monarch Pharmaceuticals Inc, to indicate its status as a supplier to defense agencies and government organizations. CAGE Codes are provided for specific facilities by the DLA, and they are crucial for streamlined communication, procurement processes, and compliance with regulations between the identified company and government agencies, particularly in the defense and federal contracting sectors. |
|
Where Can the Entity with CAGE Code 09GL2 be Found Geographically? |
|
The physical address linked to CAGE Code 09GL2 is 501 FIFTH STREET BRISTOL, TN, 37620-2304 UNITED STATES. |
|
Who Holds CAGE Code 09GL2? |
|
CAGE Code 09GL2 is held by Monarch Pharmaceuticals Inc, a prominent manufacturer with a strong presence in the defense and aerospace sectors. |
|
What Part Types Are Associated with CAGE Code 09GL2? |
|
The items commonly associated with the CAGE Code 09GL2 include Colistimethate Sodium Usp, Sulfadiazine Silver, Ramipril Capsules, Neomycin And Polymy, Theophylline Extend, and more. |
|
What NSNs Are Associated with CAGE Code 09GL2? |
|
The NSNs associated with CAGE Code 09GL2 (Monarch Pharmaceuticals Inc) include 6505001817774, 6505005607331, 6505013440489, 6505010141378, 6505010430230, and several others. |
|
What Part Numbers are Manufactured by Monarch Pharmaceuticals Inc Under CAGE Code 09GL2? |
|
Monarch Pharmaceuticals Inc, identified by CAGE Code 09GL2, produces a wide range of high-quality components, including part numbers like NDC61570-0414-51, NDC61570-0131-40, NDC61570-0112-01, NDC61570-0034-10, NDC61570-0033-10, and others. |
